Cargando…
Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Although a wide range of therapeutic options is available, the efficacy of these methods and the prognosis of patients with HCC remain very poor. This study was conducted to evaluate the efficacy and safety of viscum fraxini...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395314/ https://www.ncbi.nlm.nih.gov/pubmed/14710208 http://dx.doi.org/10.1038/sj.bjc.6601463 |